Live rotavirus vaccine (GlaxoSmithKline Biologicals)

人轮状病毒减毒活疫苗（GlaxoSmithKline Biologicals）

Report date: 2025/12/23 10:37:55

Base Information

Drug NameLive rotavirus vaccine (GlaxoSmithKline Biologicals)
Drug Alias NameGSK vaccine 444563GSK rotavirus vaccine 444563HRV Liquid - GlaxoSmithKlineRotavirus vaccine - AVANT Immunotherapeutics/GlaxoSmithKlineRotavirus vaccine 444563 - GlaxoSmithKline +[10] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSprue, TropicalGastroenteritisRotavirus Infections +[11] 
Global Approved IndicationsRotavirus Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2006/02/21
Country/TerritoryCanadaPanamaUnited States +[33] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcGlaxosmithkline Biologicals SAGlaxosmithkline (China) Investment Co Ltd
Inactive CompaniesMitsubishi Tanabe Pharma CorpUniversity Of Vermont
Active IndicationsGastroenteritisRotavirus InfectionsRespiratory Syncytial Virus Infections
Inactive IndicationsSprue, TropicalHepatitis BPoliomyelitis +[8] 

Other Information

ATC CodeJ07BH01
Related LinksN/A